Literature DB >> 18574072

A relationship between insulin sensitivity and vasodilation in women with a history of preeclamptic pregnancy.

Katja H Lampinen1, Mats Rönnback, Per-Henrik Groop, Risto J Kaaja.   

Abstract

Women with a history of preeclampsia are characterized by vascular dysfunction and an increased risk of cardiovascular disease. In the present study we investigated whether insulin sensitivity is decreased in women with previous preeclampsia and whether it is associated with endothelium-dependent and/or -independent vasodilation and/or features of metabolic syndrome. Twenty-eight nonobese women with previous severe preeclampsia and 20 women with a previous normotensive pregnancy were studied 5 to 6 years after the index pregnancy. Vasodilation was measured by venous occlusion plethysmography after intra-arterial infusions of sodium nitroprusside and acetylcholine and insulin sensitivity by the intravenous glucose tolerance test using the minimal model technique. The women were tested for lipid profile, inflammatory status and endothelial activation. Insulin sensitivity did not differ between the groups (P=0.24). Insulin sensitivity correlated positively to endothelium-dependent vasodilation only in the patient group in both low (beta=0.59; P=0.04) and high (beta=0.53; P=0.04) concentrations of acetylcholine and in a high concentration of sodium nitroprusside (beta=0.0007; P=0.006). In multivariate analysis, the waist/hip ratio (P=0.04) and serum triglycerides (P=0.04) had the most effect on insulin sensitivity in the patient group. Gestational weeks at the onset of preeclamptic hypertension (P=0.02) and proteinuria (P=0.02) associated positively with insulin sensitivity together with first-trimester body mass index (P=0.008) and maximum diastolic blood pressure during preeclampsia (P=0.005). The present study indicates a relation between insulin sensitivity with vascular dilatory function in women with previous preeclampsia. Furthermore, early onset preeclampsia correlates with impaired insulin sensitivity later in life.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18574072     DOI: 10.1161/HYPERTENSIONAHA.108.113423

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  10 in total

1.  Intraabdominal fat, insulin sensitivity, and cardiovascular risk factors in postpartum women with a history of preeclampsia.

Authors:  Darcy R Barry; Kristina M Utzschneider; Jenny Tong; Kersten Gaba; Daniel F Leotta; John D Brunzell; Thomas R Easterling
Journal:  Am J Obstet Gynecol       Date:  2015-05-21       Impact factor: 8.661

Review 2.  Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications.

Authors:  Corey E Tabit; William B Chung; Naomi M Hamburg; Joseph A Vita
Journal:  Rev Endocr Metab Disord       Date:  2010-03       Impact factor: 6.514

Review 3.  Microvascular dysfunction: an emerging pathway in the pathogenesis of obesity-related insulin resistance.

Authors:  Dennis M J Muris; Alfons J H M Houben; Miranda T Schram; Coen D A Stehouwer
Journal:  Rev Endocr Metab Disord       Date:  2013-03       Impact factor: 6.514

4.  Preeclampsia and cardiovascular disease death: prospective evidence from the child health and development studies cohort.

Authors:  Morgana L Mongraw-Chaffin; Piera M Cirillo; Barbara A Cohn
Journal:  Hypertension       Date:  2010-06-01       Impact factor: 10.190

5.  Increased plasma norepinephrine levels in previously pre-eclamptic women.

Authors:  K H Lampinen; M Rönnback; P-H Groop; M G Nicholls; T G Yandle; R J Kaaja
Journal:  J Hum Hypertens       Date:  2013-09-19       Impact factor: 3.012

6.  Changes in androgens and insulin sensitivity indexes throughout pregnancy in women with polycystic ovary syndrome (PCOS): relationships with adverse outcomes.

Authors:  Angela Falbo; Morena Rocca; Tiziana Russo; Antonietta D'Ettore; Achille Tolino; Fulvio Zullo; Francesco Orio; Stefano Palomba
Journal:  J Ovarian Res       Date:  2010-10-13       Impact factor: 4.234

Review 7.  Insulin resistance in women's health: why it matters and how to identify it.

Authors:  Richard S Legro
Journal:  Curr Opin Obstet Gynecol       Date:  2009-08       Impact factor: 1.927

8.  Association between markers of systemic inflammation, oxidative stress, lipid profiles, and insulin resistance in pregnant women.

Authors:  Zatollah Asemi; Shima Jazayeri; Mohammad Najafi; Mansooreh Samimi; Farzad Shidfar; Zohreh Tabassi; Mohamadesmaeil Shahaboddin; Ahmad Esmaillzadeh
Journal:  ARYA Atheroscler       Date:  2013-05

9.  Estimating rate of insulin resistance in patients with preeclampsia using HOMA-IR index and comparison with nonpreeclampsia pregnant women.

Authors:  Farideh Rezaei Abhari; Maryam Ghanbari Andarieh; Asadollah Farokhfar; Soleiman Ahmady
Journal:  Biomed Res Int       Date:  2014-04-09       Impact factor: 3.411

Review 10.  Preventing cardiovascular disease after hypertensive disorders of pregnancy: Searching for the how and when.

Authors:  T Katrien J Groenhof; Bas B van Rijn; Arie Franx; Jeanine E Roeters van Lennep; Michiel L Bots; A Titia Lely
Journal:  Eur J Prev Cardiol       Date:  2017-09-12       Impact factor: 7.804

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.